
    
      This observatory evaluate the effect of Bifidobacterium longum 35624 on the quality of life
      of IBS patients having different subtypes of transit pattern and different level of symptom
      severity, after a one-month treatment with Bibidobacterium longum 35624, 1x10^9 CFU/capsule,
      1 capsule/day.
    
  